Intellectual Ventures founder and CEO Nathan Myhrvold illuminates why people and the planet need every source of reliable, carbon-free energy we can get.
Read MoreInsights
Global Good is helping families prepare meals with cleaner, more efficient cooking by embedding technology into Jet Flame Cookstove.
Read MoreInsights
Global Good recently donated three INCUDIGIT-SV 30 biological culture incubators to the Governor’s office of Lagos State.
Read MoreInsights
Global Good recently conducted a World Cancer Day 2019 webinar called Artificial Intelligence for Identifying Cervical Precancer, which explores how a new Automated Visual Evaluation (AVE) technique will potentially increase access to quality cervical cancer screening worldwide.
Read MoreInsights
Intellectual Ventures founder and CEO Nathan Myhrvold illuminates why people and the planet need every source of reliable, carbon-free energy we can get.
Read MorePress Releases
The new patent licensing program will allow select vendors of Wi-Fi Direct and Miracast systems greater access to IV’s deep patent portfolio.
Read MorePress Releases
New rapid diagnostic test now available to research organizations for low parasitemia settings.
Read MorePress Releases
Incubation device features leap-frog power management and insulation technology that guarantees operation in low-resource settings with unreliable electricity.
Read MorePress Releases
GHT team to focus on inventing technology to improve the health of those who need it most.
Read MorePublications
With partners, Global Good is redesigning the window and door to keep deadly mosquitoes out of African homes.
Read MorePublications
Autoscope was tested in the Iquitos region of Peru in 2016 at two peripheral health facilities, with routine microscopy and PCR as reference standards. The main outcome measures include sensitivity and specificity of diagnosis of malaria from Giemsa-stained blood films, using PCR as reference.
Read MorePublications
Microbiological culture remains the most sensitive method for detecting viable and infectious bacteria, but these methods often require at least 24 hours to visibly identify bacterial growth.
Read MorePublications
Here, we review the principles underpinning lateral flow assays and the historical evolution of theory to predict their performance.
Read MoreMedia Coverage
VentureBeat
Evolv announced that it has raised over $30 million in series C funding.
Read MoreMedia Coverage
VentureBeat
Learn more about YouVue, the latest IV spinout to come out of stealth mode.
Read MoreMedia Coverage
GeekWire
Learn all about what fuels Brian Holloway, IV's head of the Deep Science Fund.
Read MoreMedia Coverage
GeekWire
Pivotal Commware, one of several metamaterials spinouts launched by IV, backed has secured $10 million in financing.
Read More